{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:55:42Z","timestamp":1795092942811,"version":"4.10.2"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T00:00:00Z","timestamp":1509321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T00:00:00Z","timestamp":1509321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s10875-017-0453-z","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T06:28:30Z","timestamp":1509344910000},"page":"13-27","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":196,"title":["Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6399-6042","authenticated-orcid":false,"given":"Fabio","family":"Candotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,30]]},"reference":[{"key":"453_CR1","first-page":"212","volume":"68","author":"A Wiskott","year":"1937","unstructured":"Wiskott A. Famili\u00e4rer, angeborener Morbus Werlhofii? Monatsschr Kinderheilkd. 1937;68:212\u20136.","journal-title":"Monatsschr Kinderheilkd"},{"issue":"2","key":"453_CR2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1542\/peds.13.2.133","volume":"13","author":"RA Aldrich","year":"1954","unstructured":"Aldrich RA, Steinberg AG, Campbell DC. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics. 1954;13(2):133\u20139.","journal-title":"Pediatrics"},{"issue":"1","key":"453_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0888-7543(88)90156-5","volume":"3","author":"SP Kwan","year":"1988","unstructured":"Kwan SP, Sandkuyl LA, Blaese M, Kunkel LM, Bruns G, Parmley R, et al. Genetic mapping of the Wiskott-Aldrich syndrome with two highly-linked polymorphic DNA markers. Genomics. 1988;3(1):39\u201343.","journal-title":"Genomics"},{"issue":"8675","key":"453_CR4","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S0140-6736(89)91920-X","volume":"2","author":"G de Saint Basile","year":"1989","unstructured":"de Saint Basile G, Arveiler B, Fraser NJ, Boyd Y, Graig IW, Griscelli G, et al. Close linkage of hypervariable marker DXS255 to disease locus of Wiskott-Aldrich syndrome. Lancet. 1989;2(8675):1319\u201321.","journal-title":"Lancet"},{"issue":"4","key":"453_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/0092-8674(94)90528-2","volume":"78","author":"JM Derry","year":"1994","unstructured":"Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 1994;78(4):635\u201344.","journal-title":"Cell"},{"issue":"1","key":"453_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0022-3476(80)80133-8","volume":"97","author":"GS Perry III","year":"1980","unstructured":"Perry GS III, Spector BD, Schuman LM, Mandel JS, Anderson VE, McHugh RB, et al. The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979). J Pediatr. 1980;97(1):72\u20138.","journal-title":"J Pediatr"},{"issue":"6 Pt 1","key":"453_CR7","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S0022-3476(05)82002-5","volume":"125","author":"KE Sullivan","year":"1994","unstructured":"Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr. 1994;125(6 Pt 1):876\u201385.","journal-title":"J Pediatr"},{"issue":"2","key":"453_CR8","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1182\/blood-2003-05-1480","volume":"103","author":"K Imai","year":"2004","unstructured":"Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, et al. Clinical course of patients with WASP gene mutations. Blood. 2004;103(2):456\u201364. https:\/\/doi.org\/10.1182\/blood-2003-05-1480.","journal-title":"Blood"},{"issue":"9","key":"453_CR9","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1182\/blood-2012-08-448118","volume":"121","author":"N Mahlaoui","year":"2013","unstructured":"Mahlaoui N, Pellier I, Mignot C, Jais JP, Bilhou-Nabera C, Moshous D, et al. Characteristics and outcome of early-onset, severe forms of Wiskott-Aldrich syndrome. Blood. 2013;121(9):1510\u20136. https:\/\/doi.org\/10.1182\/blood-2012-08-448118.","journal-title":"Blood"},{"issue":"10","key":"453_CR10","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1182\/blood.V86.10.3797.bloodjournal86103797","volume":"86","author":"Q Zhu","year":"1995","unstructured":"Zhu Q, Zhang M, Blaese RM, Derry JM, Junker A, Francke U, et al. The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene. Blood. 1995;86(10):3797\u2013804.","journal-title":"Blood"},{"issue":"1 Suppl","key":"453_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbmt.2008.10.007","volume":"15","author":"HD Ochs","year":"2009","unstructured":"Ochs HD, Filipovich AH, Veys P, Cowan MJ, Kapoor N. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant. 2009;15(1 Suppl):84\u201390. https:\/\/doi.org\/10.1016\/j.bbmt.2008.10.007.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"453_CR12","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/ng0495-414","volume":"9","author":"A Villa","year":"1995","unstructured":"Villa A, Notarangelo L, Macchi P, Mantuano E, Cavagni G, Brugnoni D, et al. X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet. 1995;9(4):414\u20137.","journal-title":"Nat Genet"},{"issue":"16","key":"453_CR13","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1182\/blood-2009-09-239087","volume":"115","author":"MH Albert","year":"2010","unstructured":"Albert MH, Bittner TC, Nonoyama S, Notarangelo LD, Burns S, Imai K, et al. X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options. Blood. 2010;115(16):3231\u20138. https:\/\/doi.org\/10.1182\/blood-2009-09-239087.","journal-title":"Blood"},{"issue":"9","key":"453_CR14","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/pbc.25559","volume":"62","author":"DW Liu","year":"2015","unstructured":"Liu DW, Zhang ZY, Zhao Q, Jiang LP, Liu W, Tu WW, et al. Wiskott-Aldrich syndrome\/X-linked thrombocytopenia in China: clinical characteristic and genotype-phenotype correlation. Pediatr Blood Cancer. 2015;62(9):1601\u20138. https:\/\/doi.org\/10.1002\/pbc.25559.","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"453_CR15","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/pbc.22920","volume":"56","author":"PD Patel","year":"2011","unstructured":"Patel PD, Samanich JM, Mitchell WB, Manwani D. A unique presentation of Wiskott-Aldrich syndrome in relation to platelet size. Pediatr Blood Cancer. 2011;56(7):1127\u20139. https:\/\/doi.org\/10.1002\/pbc.22920.","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"453_CR16","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1002\/pbc.25196","volume":"61","author":"E Mantadakis","year":"2014","unstructured":"Mantadakis E, Sawalle-Belohradsky J, Tzanoudaki M, Kanariou M, Chatzimichael A, Albert MH. X-linked thrombocytopenia in three males with normal sized platelets due to novel WAS gene mutations. Pediatr Blood Cancer. 2014;61(12):2305\u20136. https:\/\/doi.org\/10.1002\/pbc.25196.","journal-title":"Pediatr Blood Cancer"},{"key":"453_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2015.00049","volume":"3","author":"R Sokolic","year":"2015","unstructured":"Sokolic R, Oden N, Candotti F. Assessment of immature platelet fraction in the diagnosis of Wiskott-Aldrich syndrome. Front Pediatr. 2015;3:49. https:\/\/doi.org\/10.3389\/fped.2015.00049.","journal-title":"Front Pediatr"},{"issue":"1","key":"453_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13256-016-0944-1","volume":"10","author":"MF Baharin","year":"2016","unstructured":"Baharin MF, Dhaliwal JS, Sarachandran SV, Idris SZ, Yeoh SL. A rare case of Wiskott-Aldrich syndrome with normal platelet size: a case report. J Med Case Rep. 2016;10(1):188. https:\/\/doi.org\/10.1186\/s13256-016-0944-1.","journal-title":"J Med Case Rep"},{"issue":"4","key":"453_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/09537104.2016.1246715","volume":"28","author":"JM Bastida","year":"2017","unstructured":"Bastida JM, Del Rey M, Revilla N, Benito R, Perez-Andres M, Gonzalez B, et al. Wiskott-Aldrich syndrome in a child presenting with macrothrombocytopenia. Platelets. 2017;28(4):417\u201320. https:\/\/doi.org\/10.1080\/09537104.2016.1246715.","journal-title":"Platelets"},{"issue":"2","key":"453_CR20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1182\/blood.V94.2.509","volume":"94","author":"E Haddad","year":"1999","unstructured":"Haddad E, Cramer E, Riviere C, Rameau P, Louache F, Guichard J, et al. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation. Blood. 1999;94(2):509\u201318.","journal-title":"Blood"},{"issue":"2","key":"453_CR21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood.V55.2.243.243","volume":"55","author":"HD Ochs","year":"1980","unstructured":"Ochs HD, Slichter SJ, Harker LA, Von Behrens WE, Clark RA, Wedgwood RJ. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood. 1980;55(2):243\u201352.","journal-title":"Blood"},{"issue":"4","key":"453_CR22","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1046\/j.1365-2141.1997.1132938.x","volume":"97","author":"JW Semple","year":"1997","unstructured":"Semple JW, Siminovitch KA, Mody M, Milev Y, Lazarus AH, Wright JF, et al. Flow cytometric analysis of platelets from children with the Wiskott- Aldrich syndrome reveals defects in platelet development, activation and structure. Br J Haematol. 1997;97(4):747\u201354.","journal-title":"Br J Haematol"},{"issue":"4","key":"453_CR23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3109\/09537104.2012.693991","volume":"24","author":"A Prislovsky","year":"2013","unstructured":"Prislovsky A, Zeng X, Sokolic RA, Garabedian EN, Anur P, Candotti F, et al. Platelets from WAS patients show an increased susceptibility to ex vivo phagocytosis. Platelets. 2013;24(4):288\u201396. https:\/\/doi.org\/10.3109\/09537104.2012.693991.","journal-title":"Platelets"},{"issue":"11","key":"453_CR24","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1182\/blood-2014-09-602573","volume":"126","author":"AJ Gerrits","year":"2015","unstructured":"Gerrits AJ, Leven EA, Frelinger AL III, Brigstocke SL, Berny-Lang MA, Mitchell WB, et al. Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome\/X-linked thrombocytopenia. Blood. 2015;126(11):1367\u201378. https:\/\/doi.org\/10.1182\/blood-2014-09-602573.","journal-title":"Blood"},{"issue":"4","key":"453_CR25","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1160\/TH14-06-0503","volume":"113","author":"P Ingrungruanglert","year":"2015","unstructured":"Ingrungruanglert P, Amarinthnukrowh P, Rungsiwiwut R, Maneesri-le Grand S, Sosothikul D, Suphapeetiporn K, et al. Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation. Thromb Haemost. 2015;113(4):792\u2013805. https:\/\/doi.org\/10.1160\/TH14-06-0503.","journal-title":"Thromb Haemost"},{"issue":"10","key":"453_CR26","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1182\/blood.V82.10.2961.2961","volume":"82","author":"CA Mullen","year":"1993","unstructured":"Mullen CA, Anderson KD, Blaese RM. Splenectomy and\/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 cases. Blood. 1993;82(10):2961\u20136.","journal-title":"Blood"},{"issue":"5","key":"453_CR27","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1136\/adc.75.5.436","volume":"75","author":"J Litzman","year":"1996","unstructured":"Litzman J, Jones A, Hann I, Chapel H, Strobel S, Morgan G. Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome. Arch Dis Child. 1996;75(5):436\u20139.","journal-title":"Arch Dis Child"},{"issue":"4","key":"453_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1365-2141.1969.tb01383.x","volume":"17","author":"KA Grottum","year":"1969","unstructured":"Grottum KA, Hovig T, Holmsen H, Abrahamsen AF, Jeremic M, Seip M. Wiskott-Aldrich syndrome: qualitative platelet defects and short platelet survival. Br J Haematol. 1969;17(4):373\u201388.","journal-title":"Br J Haematol"},{"key":"453_CR29","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1749-6632.1972.tb16316.x","volume":"201","author":"MG Baldini","year":"1972","unstructured":"Baldini MG. Nature of the platelet defect in the Wiskott-Aldrich syndrome. Ann N Y Acad Sci. 1972;201:437\u201344.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"453_CR30","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1399-3038.2010.00996.x","volume":"21","author":"ZY Zhang","year":"2010","unstructured":"Zhang ZY, Xiao HQ, Jiang LP, Zhou Y, Zhao Q, Yu J, et al. Analysis of clinical and molecular characteristics of Wiskott-Aldrich syndrome in 24 patients from 23 unrelated Chinese families. Pediatr Allergy Immunol. 2010;21(3):522\u201332. https:\/\/doi.org\/10.1111\/j.1399-3038.2010.00996.x.","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"453_CR31","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4049\/jimmunol.161.2.1026","volume":"161","author":"R Badolato","year":"1998","unstructured":"Badolato R, Sozzani S, Malacarne F, Bresciani S, Fiorini M, Borsatti A, et al. Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. J Immunol. 1998;161(2):1026\u201333.","journal-title":"J Immunol"},{"issue":"4","key":"453_CR32","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1046\/j.1365-2141.1998.00767.x","volume":"101","author":"D Zicha","year":"1998","unstructured":"Zicha D, Allen WE, Brickell PM, Kinnon C, Dunn GA, Jones GE, et al. Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br J Haematol. 1998;101(4):659\u201365.","journal-title":"Br J Haematol"},{"issue":"17","key":"453_CR33","doi-asserted-by":"publisher","first-page":"9648","DOI":"10.1073\/pnas.96.17.9648","volume":"96","author":"S Linder","year":"1999","unstructured":"Linder S, Nelson D, Weiss M, Aepfelbacher M. Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc Natl Acad Sci U S A. 1999;96(17):9648\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"453_CR34","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood.V95.9.2943.009k17_2943_2946","volume":"95","author":"R Lorenzi","year":"2000","unstructured":"Lorenzi R, Brickell PM, Katz DR, Kinnon C, Thrasher AJ. Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis. Blood. 2000;95(9):2943\u20136.","journal-title":"Blood"},{"issue":"2","key":"453_CR35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.immuni.2006.06.014","volume":"25","author":"H Zhang","year":"2006","unstructured":"Zhang H, Schaff UY, Green CE, Chen H, Sarantos MR, Hu Y, et al. Impaired integrin-dependent function in Wiskott-Aldrich syndrome protein-deficient murine and human neutrophils. Immunity. 2006;25(2):285\u201395. https:\/\/doi.org\/10.1016\/j.immuni.2006.06.014.","journal-title":"Immunity"},{"issue":"10","key":"453_CR36","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3259::AID-IMMU3259>3.0.CO;2-B","volume":"28","author":"M Binks","year":"1998","unstructured":"Binks M, Jones GE, Brickell PM, Kinnon C, Katz DR, Thrasher AJ. Intrinsic dendritic cell abnormalities in Wiskott-Aldrich syndrome. Eur J Immunol. 1998;28(10):3259\u201367. https:\/\/doi.org\/10.1002\/(SICI)1521-4141(199810)28:10&#60;3259::AID-IMMU3259&#62;3.0.CO;2-B.","journal-title":"Eur J Immunol"},{"issue":"2","key":"453_CR37","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.4049\/jimmunol.181.2.1135","volume":"181","author":"J Pulecio","year":"2008","unstructured":"Pulecio J, Tagliani E, Scholer A, Prete F, Fetler L, Burrone OR, et al. Expression of Wiskott-Aldrich syndrome protein in dendritic cells regulates synapse formation and activation of naive CD8+ T cells. J Immunol. 2008;181(2):1135\u201342.","journal-title":"J Immunol"},{"issue":"9","key":"453_CR38","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1182\/blood-2011-03-340265","volume":"118","author":"G Bouma","year":"2011","unstructured":"Bouma G, Mendoza-Naranjo A, Blundell MP, de Falco E, Parsley KL, Burns SO, et al. Cytoskeletal remodeling mediated by WASp in dendritic cells is necessary for normal immune synapse formation and T-cell priming. Blood. 2011;118(9):2492\u2013501. https:\/\/doi.org\/10.1182\/blood-2011-03-340265.","journal-title":"Blood"},{"issue":"14","key":"453_CR39","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1182\/blood-2009-07-235804","volume":"115","author":"H Stabile","year":"2010","unstructured":"Stabile H, Carlino C, Mazza C, Giliani S, Morrone S, Notarangelo LD, et al. Impaired NK-cell migration in WAS\/XLT patients: role of Cdc42\/WASp pathway in the control of chemokine-induced beta2 integrin high-affinity state. Blood. 2010;115(14):2818\u201326. https:\/\/doi.org\/10.1182\/blood-2009-07-235804.","journal-title":"Blood"},{"issue":"17","key":"453_CR40","doi-asserted-by":"publisher","first-page":"11351","DOI":"10.1073\/pnas.162376099","volume":"99","author":"JS Orange","year":"2002","unstructured":"Orange JS, Ramesh N, Remold-O'Donnell E, Sasahara Y, Koopman L, Byrne M, et al. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci U S A. 2002;99(17):11351\u20136. https:\/\/doi.org\/10.1073\/pnas.162376099.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"453_CR41","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.4049\/jimmunol.174.5.2602","volume":"174","author":"W Huang","year":"2005","unstructured":"Huang W, Ochs HD, Dupont B, Vyas YM. The Wiskott-Aldrich syndrome protein regulates nuclear translocation of NFAT2 and NF-kappa B (RelA) independently of its role in filamentous actin polymerization and actin cytoskeletal rearrangement. J Immunol. 2005;174(5):2602\u201311.","journal-title":"J Immunol"},{"issue":"2","key":"453_CR42","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1182\/blood-2003-07-2621","volume":"104","author":"A Gismondi","year":"2004","unstructured":"Gismondi A, Cifaldi L, Mazza C, Giliani S, Parolini S, Morrone S, et al. Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect. Blood. 2004;104(2):436\u201343. https:\/\/doi.org\/10.1182\/blood-2003-07-2621.","journal-title":"Blood"},{"issue":"1","key":"453_CR43","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2249.2004.02409.x","volume":"136","author":"JY Park","year":"2004","unstructured":"Park JY, Kob M, Prodeus AP, Rosen FS, Shcherbina A, Remold-O\u2019Donnell E. Early deficit of lymphocytes in Wiskott-Aldrich syndrome: possible role of WASP in human lymphocyte maturation. Clin Exp Immunol. 2004;136(1):104\u201310.","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"453_CR44","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood.V94.11.3872","volume":"94","author":"SL Rawlings","year":"1999","unstructured":"Rawlings SL, Crooks GM, Bockstoce D, Barsky LW, Parkman R, Weinberg KI. Spontaneous apoptosis in lymphocytes from patients with Wiskott-Aldrich syndrome: correlation of accelerated cell death and attenuated bcl-2 expression. Blood. 1999;94(11):3872\u201382.","journal-title":"Blood"},{"issue":"12","key":"453_CR45","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1182\/blood-2005-06-2336","volume":"106","author":"T Wada","year":"2005","unstructured":"Wada T, Schurman SH, Garabedian EK, Yachie A, Candotti F. Analysis of T-cell repertoire diversity in Wiskott-Aldrich syndrome. Blood. 2005;106(12):3895\u20137. https:\/\/doi.org\/10.1182\/blood-2005-06-2336.","journal-title":"Blood"},{"issue":"1","key":"453_CR46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jaci.2014.06.025","volume":"135","author":"J Wu","year":"2015","unstructured":"Wu J, Liu D, Tu W, Song W, Zhao X. T-cell receptor diversity is selectively skewed in T-cell populations of patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2015;135(1):209\u201316. https:\/\/doi.org\/10.1016\/j.jaci.2014.06.025.","journal-title":"J Allergy Clin Immunol"},{"key":"453_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00340","volume":"5","author":"AE O'Connell","year":"2014","unstructured":"O'Connell AE, Volpi S, Dobbs K, Fiorini C, Tsitsikov E, de Boer H, et al. Next generation sequencing reveals skewing of the T and B cell receptor repertoires in patients with Wiskott-Aldrich syndrome. Front Immunol. 2014;5:340. https:\/\/doi.org\/10.3389\/fimmu.2014.00340.","journal-title":"Front Immunol"},{"issue":"3","key":"453_CR48","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1084\/jem.176.3.867","volume":"176","author":"IJ Molina","year":"1992","unstructured":"Molina IJ, Kenney DM, Rosen FS, Remold ODE. T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome. J Exp Med. 1992;176(3):867\u201374.","journal-title":"J Exp Med"},{"issue":"8","key":"453_CR49","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.4049\/jimmunol.151.8.4383","volume":"151","author":"IJ Molina","year":"1993","unstructured":"Molina IJ, Sancho J, Terhorst C, Rosen FS, Remold ODE. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J Immunol. 1993;151(8):4383\u201390.","journal-title":"J Immunol"},{"issue":"1","key":"453_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1182\/blood.V97.1.33","volume":"97","author":"E Haddad","year":"2001","unstructured":"Haddad E, Zugaza JL, Louache F, Debili N, Crouin C, Schwarz K, et al. The interaction between Cdc42 and WASP is required for SDF-1-induced T- lymphocyte chemotaxis. Blood. 2001;97(1):33\u20138.","journal-title":"Blood"},{"issue":"2","key":"453_CR51","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1074-7613(02)00360-6","volume":"17","author":"L Dupre","year":"2002","unstructured":"Dupre L, Aiuti A, Trifari S, Martino S, Saracco P, Bordignon C, et al. Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity. 2002;17(2):157\u201366.","journal-title":"Immunity"},{"issue":"10","key":"453_CR52","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3324\/haematol.2011.040204","volume":"96","author":"R Calvez","year":"2011","unstructured":"Calvez R, Lafouresse F, De Meester J, Galy A, Valitutti S, Dupre L. The Wiskott-Aldrich syndrome protein permits assembly of a focused immunological synapse enabling sustained T-cell receptor signaling. Haematologica. 2011;96(10):1415\u201323. https:\/\/doi.org\/10.3324\/haematol.2011.040204.","journal-title":"Haematologica"},{"issue":"25","key":"453_CR53","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1182\/blood-2015-06-652636","volume":"127","author":"X Zhang","year":"2016","unstructured":"Zhang X, Dai R, Li W, Zhao H, Zhang Y, Zhou L, et al. Abnormalities of follicular helper T-cell number and function in Wiskott-Aldrich syndrome. Blood. 2016;127(25):3180\u201391. https:\/\/doi.org\/10.1182\/blood-2015-06-652636.","journal-title":"Blood"},{"key":"453_CR54","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jaut.2013.10.006","volume":"50","author":"MC Castiello","year":"2014","unstructured":"Castiello MC, Bosticardo M, Pala F, Catucci M, Chamberlain N, van Zelm MC, et al. Wiskott-Aldrich syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans. J Autoimmun. 2014;50:42\u201350. https:\/\/doi.org\/10.1016\/j.jaut.2013.10.006.","journal-title":"J Autoimmun"},{"issue":"2","key":"453_CR55","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1365-2249.2005.02693.x","volume":"139","author":"JY Park","year":"2005","unstructured":"Park JY, Shcherbina A, Rosen FS, Prodeus AP, Remold-O\u2019Donnell E. Phenotypic perturbation of B cells in the Wiskott-Aldrich syndrome. Clin Exp Immunol. 2005;139(2):297\u2013305. https:\/\/doi.org\/10.1111\/j.1365-2249.2005.02693.x.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"453_CR56","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jaci.2013.08.050","volume":"133","author":"KL Simon","year":"2014","unstructured":"Simon KL, Anderson SM, Garabedian EK, Moratto D, Sokolic RA, Candotti F. Molecular and phenotypic abnormalities of B lymphocytes in patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2014;133(3):896\u2013899 e4. https:\/\/doi.org\/10.1016\/j.jaci.2013.08.050.","journal-title":"J Allergy Clin Immunol"},{"issue":"5 Pt 1","key":"453_CR57","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1542\/peds.111.5.e622","volume":"111","author":"S Dupuis-Girod","year":"2003","unstructured":"Dupuis-Girod S, Medioni J, Haddad E, Quartier P, Cavazzana-Calvo M, Le Deist F, et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics. 2003;111(5 Pt 1):e622\u20137.","journal-title":"Pediatrics"},{"issue":"1","key":"453_CR58","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1182\/blood-2007-03-076679","volume":"111","author":"H Ozsahin","year":"2008","unstructured":"Ozsahin H, Cavazzana-Calvo M, Notarangelo LD, Schulz A, Thrasher AJ, Mazzolari E, et al. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. Blood. 2008;111(1):439\u201345. https:\/\/doi.org\/10.1182\/blood-2007-03-076679.","journal-title":"Blood"},{"issue":"6","key":"453_CR59","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1182\/blood-2010-11-319376","volume":"118","author":"D Moratto","year":"2011","unstructured":"Moratto D, Giliani S, Bonfim C, Mazzolari E, Fischer A, Ochs HD, et al. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study. Blood. 2011;118(6):1675\u201384. https:\/\/doi.org\/10.1182\/blood-2010-11-319376.","journal-title":"Blood"},{"issue":"4","key":"453_CR60","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/00002281-200307000-00012","volume":"15","author":"SH Schurman","year":"2003","unstructured":"Schurman SH, Candotti F. Autoimmunity in Wiskott-Aldrich syndrome. Curr Opin Rheumatol. 2003;15(4):446\u201353.","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"453_CR61","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00431-015-2527-3","volume":"174","author":"N Chen","year":"2015","unstructured":"Chen N, Zhang ZY, Liu DW, Liu W, Tang XM, Zhao XD. The clinical features of autoimmunity in 53 patients with Wiskott-Aldrich syndrome in China: a single-center study. Eur J Pediatr. 2015;174(10):1311\u20138. https:\/\/doi.org\/10.1007\/s00431-015-2527-3.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"453_CR62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clim.2007.02.001","volume":"124","author":"M Adriani","year":"2007","unstructured":"Adriani M, Aoki J, Horai R, Thornton AM, Konno A, Kirby M, et al. Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome. Clin Immunol. 2007;124(1):41\u20138. https:\/\/doi.org\/10.1016\/j.clim.2007.02.001.","journal-title":"Clin Immunol"},{"issue":"2","key":"453_CR63","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1084\/jem.20061334","volume":"204","author":"F Marangoni","year":"2007","unstructured":"Marangoni F, Trifari S, Scaramuzza S, Panaroni C, Martino S, Notarangelo LD, et al. WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells. J Exp Med. 2007;204(2):369\u201380. https:\/\/doi.org\/10.1084\/jem.20061334.","journal-title":"J Exp Med"},{"issue":"11","key":"453_CR64","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1084\/jem.193.11.1303","volume":"193","author":"D Dieckmann","year":"2001","unstructured":"Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med. 2001;193(11):1303\u201310.","journal-title":"J Exp Med"},{"key":"453_CR65","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.0105-2896.2006.00417.x","volume":"212","author":"C Baecher-Allan","year":"2006","unstructured":"Baecher-Allan C, Hafler DA. Human regulatory T cells and their role in autoimmune disease. Immunol Rev. 2006;212:203\u201316. https:\/\/doi.org\/10.1111\/j.0105-2896.2006.00417.x.","journal-title":"Immunol Rev"},{"issue":"9","key":"453_CR66","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1002\/eji.201344245","volume":"44","author":"G Bouma","year":"2014","unstructured":"Bouma G, Carter NA, Recher M, Malinova D, Adriani M, Notarangelo LD, et al. Exacerbated experimental arthritis in Wiskott-Aldrich syndrome protein deficiency: modulatory role of regulatory B cells. Eur J Immunol. 2014;44(9):2692\u2013702. https:\/\/doi.org\/10.1002\/eji.201344245.","journal-title":"Eur J Immunol"},{"issue":"6","key":"453_CR67","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/sji.12282","volume":"81","author":"HQ Du","year":"2015","unstructured":"Du HQ, Zhang X, An YF, Ding Y, Zhao XD. Effects of Wiskott-Aldrich syndrome protein deficiency on IL-10-producing regulatory B cells in humans and mice. Scand J Immunol. 2015;81(6):483\u201393. https:\/\/doi.org\/10.1111\/sji.12282.","journal-title":"Scand J Immunol"},{"issue":"5","key":"453_CR68","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.jaci.2015.08.010","volume":"136","author":"E Crestani","year":"2015","unstructured":"Crestani E, Volpi S, Candotti F, Giliani S, Notarangelo LD, Chu J, et al. Broad spectrum of autoantibodies in patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia. J Allergy Clin Immunol. 2015;136(5):1401\u20131404 e1\u20133. https:\/\/doi.org\/10.1016\/j.jaci.2015.08.010.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"453_CR69","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1172\/JCI82249","volume":"125","author":"F Pala","year":"2015","unstructured":"Pala F, Morbach H, Castiello MC, Schickel JN, Scaramuzza S, Chamberlain N, et al. Lentiviral-mediated gene therapy restores B cell tolerance in Wiskott-Aldrich syndrome patients. J Clin Invest. 2015;125(10):3941\u201351. https:\/\/doi.org\/10.1172\/JCI82249.","journal-title":"J Clin Invest"},{"issue":"10","key":"453_CR70","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1084\/jem.20150585","volume":"212","author":"NS Kolhatkar","year":"2015","unstructured":"Kolhatkar NS, Brahmandam A, Thouvenel CD, Becker-Herman S, Jacobs HM, Schwartz MA, et al. Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome. J Exp Med. 2015;212(10):1663\u201377. https:\/\/doi.org\/10.1084\/jem.20150585.","journal-title":"J Exp Med"},{"issue":"9","key":"453_CR71","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2012-09-457465","volume":"121","author":"T Kinnunen","year":"2013","unstructured":"Kinnunen T, Chamberlain N, Morbach H, Choi J, Kim S, Craft J, et al. Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells. Blood. 2013;121(9):1595\u2013603. https:\/\/doi.org\/10.1182\/blood-2012-09-457465.","journal-title":"Blood"},{"issue":"2","key":"453_CR72","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jaci.2012.08.040","volume":"131","author":"M Shimizu","year":"2013","unstructured":"Shimizu M, Kanegane H, Wada T, Motoyoshi Y, Morio T, Candotti F, et al. Aberrant glycosylation of IgA in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. J Allergy Clin Immunol. 2013;131(2):587\u2013590 e1\u20133. https:\/\/doi.org\/10.1016\/j.jaci.2012.08.040.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"453_CR73","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1172\/JCI5535","volume":"104","author":"M Tomana","year":"1999","unstructured":"Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest. 1999;104(1):73\u201381. https:\/\/doi.org\/10.1172\/JCI5535.","journal-title":"J Clin Invest"},{"issue":"3","key":"453_CR74","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1365-2249.2008.03703.x","volume":"153","author":"SR Chintalacharuvu","year":"2008","unstructured":"Chintalacharuvu SR, Yamashita M, Bagheri N, Blanchard TG, Nedrud JG, Lamm ME, et al. T cell cytokine polarity as a determinant of immunoglobulin A (IgA) glycosylation and the severity of experimental IgA nephropathy. Clin Exp Immunol. 2008;153(3):456\u201362. https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03703.x.","journal-title":"Clin Exp Immunol"},{"issue":"37","key":"453_CR75","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000813","volume":"2","author":"MD Taylor","year":"2010","unstructured":"Taylor MD, Sadhukhan S, Kottangada P, Ramgopal A, Sarkar K, D'Silva S, et al. Nuclear role of WASp in the pathogenesis of dysregulated TH1 immunity in human Wiskott-Aldrich syndrome. Sci Transl Med. 2010;2(37):37ra44. https:\/\/doi.org\/10.1126\/scitranslmed.3000813.","journal-title":"Sci Transl Med"},{"issue":"10","key":"453_CR76","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1172\/JCI85129","volume":"126","author":"WS Lexmond","year":"2016","unstructured":"Lexmond WS, Goettel JA, Lyons JJ, Jacobse J, Deken MM, Lawrence MG, et al. FOXP3+ Tregs require WASP to restrain Th2-mediated food allergy. J Clin Invest. 2016;126(10):4030\u201344. https:\/\/doi.org\/10.1172\/JCI85129.","journal-title":"J Clin Invest"},{"issue":"10","key":"453_CR77","doi-asserted-by":"publisher","first-page":"7451","DOI":"10.4049\/jimmunol.177.10.7451","volume":"177","author":"S Trifari","year":"2006","unstructured":"Trifari S, Sitia G, Aiuti A, Scaramuzza S, Marangoni F, Guidotti LG, et al. Defective Th1 cytokine gene transcription in CD4+ and CD8+ T cells from Wiskott-Aldrich syndrome patients. J Immunol. 2006;177(10):7451\u201361.","journal-title":"J Immunol"},{"issue":"3","key":"453_CR78","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/cea.12495","volume":"45","author":"W Peng","year":"2015","unstructured":"Peng W, Novak N. Pathogenesis of atopic dermatitis. Clin Exp Allergy. 2015;45(3):566\u201374. https:\/\/doi.org\/10.1111\/cea.12495.","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"453_CR79","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jaci.2014.09.024","volume":"135","author":"KS Tuano","year":"2015","unstructured":"Tuano KS, Orange JS, Sullivan K, Cunningham-Rundles C, Bonilla FA, Davis CM. Food allergy in patients with primary immunodeficiency diseases: prevalence within the US Immunodeficiency Network (USIDNET). J Allergy Clin Immunol. 2015;135(1):273\u20135. https:\/\/doi.org\/10.1016\/j.jaci.2014.09.024.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"453_CR80","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3109\/07357908509039813","volume":"3","author":"JD Cotelingam","year":"1985","unstructured":"Cotelingam JD, Witebsky FG, Hsu SM, Blaese RM, Jaffe ES. Malignant lymphoma in patients with the Wiskott-Aldrich syndrome. Cancer Investig. 1985;3(6):515\u201322.","journal-title":"Cancer Investig"},{"issue":"7","key":"453_CR81","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00431-006-0107-2","volume":"165","author":"C Picard","year":"2006","unstructured":"Picard C, Mellouli F, Duprez R, Chedeville G, Neven B, Fraitag S, et al. Kaposi\u2019s sarcoma in a child with Wiskott-Aldrich syndrome. Eur J Pediatr. 2006;165(7):453\u20137. https:\/\/doi.org\/10.1007\/s00431-006-0107-2.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"453_CR82","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/pbc.24359","volume":"60","author":"A Yoshimi","year":"2013","unstructured":"Yoshimi A, Kamachi Y, Imai K, Watanabe N, Nakadate H, Kanazawa T, et al. Wiskott-Aldrich syndrome presenting with a clinical picture mimicking juvenile myelomonocytic leukaemia. Pediatr Blood Cancer. 2013;60(5):836\u201341. https:\/\/doi.org\/10.1002\/pbc.24359.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"453_CR83","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1189\/jlb.0410197","volume":"88","author":"J De Meester","year":"2010","unstructured":"De Meester J, Calvez R, Valitutti S, Dupre L. The Wiskott-Aldrich syndrome protein regulates CTL cytotoxicity and is required for efficient killing of B cell lymphoma targets. J Leukoc Biol. 2010;88(5):1031\u201340. https:\/\/doi.org\/10.1189\/jlb.0410197.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"453_CR84","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1586\/1744666X.3.5.813","volume":"3","author":"D Moratto","year":"2007","unstructured":"Moratto D, Giliani S, Notarangelo LD, Mazza C, Mazzolari E, Notarangelo LD. The Wiskott-Aldrich syndrome: from genotype-phenotype correlation to treatment. Expert Rev Clin Immunol. 2007;3(5):813\u201324. https:\/\/doi.org\/10.1586\/1744666X.3.5.813.","journal-title":"Expert Rev Clin Immunol"},{"issue":"13","key":"453_CR85","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1182\/blood-2003-05-1592","volume":"104","author":"Y Jin","year":"2004","unstructured":"Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P, et al. Mutations of the Wiskott-Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype\/genotype correlation. Blood. 2004;104(13):4010\u20139.","journal-title":"Blood"},{"issue":"3","key":"453_CR86","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1046\/j.1365-2141.2003.04310.x","volume":"121","author":"A Shcherbina","year":"2003","unstructured":"Shcherbina A, Candotti F, Rosen FS, Remold-O\u2019Donnell E. High incidence of lymphomas in a subgroup of Wiskott-Aldrich syndrome patients. Br J Haematol. 2003;121(3):529\u201330.","journal-title":"Br J Haematol"},{"issue":"3","key":"453_CR87","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nri2724","volume":"10","author":"AJ Thrasher","year":"2010","unstructured":"Thrasher AJ, Burns SO. WASP: a key immunological multitasker. Nat Rev Immunol. 2010;10(3):182\u201392. https:\/\/doi.org\/10.1038\/nri2724.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"453_CR88","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/imr.12112","volume":"256","author":"O Matalon","year":"2013","unstructured":"Matalon O, Reicher B, Barda-Saad M. Wiskott-Aldrich syndrome protein\u2014dynamic regulation of actin homeostasis: from activation through function and signal termination in T lymphocytes. Immunol Rev. 2013;256(1):10\u201329. https:\/\/doi.org\/10.1111\/imr.12112.","journal-title":"Immunol Rev"},{"issue":"1","key":"453_CR89","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4049\/jimmunol.1302923","volume":"193","author":"S Sadhukhan","year":"2014","unstructured":"Sadhukhan S, Sarkar K, Taylor M, Candotti F, Vyas YM. Nuclear role of WASp in gene transcription is uncoupled from its ARP2\/3-dependent cytoplasmic role in actin polymerization. J Immunol. 2014;193(1):150\u201360. https:\/\/doi.org\/10.4049\/jimmunol.1302923.","journal-title":"J Immunol"},{"issue":"8","key":"453_CR90","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.4049\/jimmunol.166.8.5245","volume":"166","author":"T Ariga","year":"2001","unstructured":"Ariga T, Kondoh T, Yamaguchi K, Yamada M, Sasaki S, Nelson DL, et al. Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome. J Immunol. 2001;166(8):5245\u20139.","journal-title":"J Immunol"},{"issue":"15","key":"453_CR91","doi-asserted-by":"publisher","first-page":"8697","DOI":"10.1073\/pnas.151260498","volume":"98","author":"T Wada","year":"2001","unstructured":"Wada T, Schurman SH, Otsu M, Garabedian EK, Ochs HD, Nelson DL, et al. Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc Natl Acad Sci U S A. 2001;98(15):8697\u2013702. https:\/\/doi.org\/10.1073\/pnas.151260498.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"453_CR92","first-page":"1802","volume":"100","author":"MI Lutskiy","year":"2002","unstructured":"Lutskiy MI, Rosen FS, Remold-O\u2019Donnell E. Spontaneous correction of the T-cell defect in patients with the Wiskott-Aldrich syndrome. Blood. 2002;100(11):1802.","journal-title":"Blood"},{"issue":"9","key":"453_CR93","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1172\/JCI15485","volume":"111","author":"T Wada","year":"2003","unstructured":"Wada T, Konno A, Schurman SH, Garabedian EK, Anderson SM, Kirby M, et al. Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings. J Clin Invest. 2003;111(9):1389\u201397. https:\/\/doi.org\/10.1172\/JCI15485.","journal-title":"J Clin Invest"},{"issue":"2","key":"453_CR94","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1182\/blood-2003-05-1739","volume":"103","author":"A Konno","year":"2004","unstructured":"Konno A, Wada T, Schurman SH, Garabedian EK, Kirby M, Anderson SM, et al. Differential contribution of Wiskott-Aldrich syndrome protein to selective advantage in T- and B-cell lineages. Blood. 2004;103(2):676\u20138. https:\/\/doi.org\/10.1182\/blood-2003-05-1739.","journal-title":"Blood"},{"issue":"5","key":"453_CR95","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1182\/blood-2004-03-0846","volume":"104","author":"T Wada","year":"2004","unstructured":"Wada T, Schurman SH, Jagadeesh GJ, Garabedian EK, Nelson DL, Candotti F. Multiple patients with revertant mosaicism in a single Wiskott-Aldrich syndrome family. Blood. 2004;104(5):1270\u20132. https:\/\/doi.org\/10.1182\/blood-2004-03-0846.","journal-title":"Blood"},{"issue":"8","key":"453_CR96","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1182\/blood-2004-12-4724","volume":"106","author":"MI Lutskiy","year":"2005","unstructured":"Lutskiy MI, Beardsley DS, Rosen FS, Remold-O\u2019Donnell E. Mosaicism of NK cells in a patient with Wiskott-Aldrich syndrome. Blood. 2005;106(8):2815\u20137.","journal-title":"Blood"},{"issue":"4","key":"453_CR97","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/humu.20308","volume":"27","author":"W Du","year":"2006","unstructured":"Du W, Kumaki S, Uchiyama T, Yachie A, Yeng Looi C, Kawai S, et al. A second-site mutation in the initiation codon of WAS (WASP) results in expansion of subsets of lymphocytes in an Wiskott-Aldrich syndrome patient. Hum Mutat. 2006;27(4):370\u20135. https:\/\/doi.org\/10.1002\/humu.20308.","journal-title":"Hum Mutat"},{"issue":"3","key":"453_CR98","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.3324\/haematol.11222","volume":"92","author":"K Boztug","year":"2007","unstructured":"Boztug K, Baumann U, Ballmaier M, Webster D, Sandrock I, Jacobs R, et al. Large granular lymphocyte proliferation and revertant mosaicism: two rare events in a Wiskott-Aldrich syndrome patient. Haematologica. 2007;92(3):e43\u20135.","journal-title":"Haematologica"},{"issue":"6","key":"453_CR99","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s10875-007-9121-z","volume":"27","author":"DM Stewart","year":"2007","unstructured":"Stewart DM, Candotti F, Nelson DL. The phenomenon of spontaneous genetic reversions in the Wiskott-Aldrich syndrome: a report of the workshop of the ESID Genetics Working Party at the XIIth Meeting of the European Society for Immunodeficiencies (ESID). Budapest, Hungary October 4-7, 2006. J Clin Immunol. 2007;27(6):634\u20139. https:\/\/doi.org\/10.1007\/s10875-007-9121-z.","journal-title":"J Clin Immunol"},{"issue":"10","key":"453_CR100","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1182\/blood-2007-06-095299","volume":"111","author":"BR Davis","year":"2008","unstructured":"Davis BR, Dicola MJ, Prokopishyn NL, Rosenberg JB, Moratto D, Muul LM, et al. Unprecedented diversity of genotypic revertants in lymphocytes of a patient with Wiskott-Aldrich syndrome. Blood. 2008;111(10):5064\u20137. https:\/\/doi.org\/10.1182\/blood-2007-06-095299.","journal-title":"Blood"},{"issue":"1","key":"453_CR101","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1399-0004.2008.01019.x","volume":"74","author":"K Boztug","year":"2008","unstructured":"Boztug K, Germeshausen M, Avedillo Diez I, Gulacsy V, Diestelhorst J, Ballmaier M, et al. Multiple independent second-site mutations in two siblings with somatic mosaicism for Wiskott-Aldrich syndrome. Clin Genet. 2008;74(1):68\u201374. https:\/\/doi.org\/10.1111\/j.1399-0004.2008.01019.x.","journal-title":"Clin Genet"},{"issue":"10","key":"453_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003444","volume":"3","author":"MI Lutskiy","year":"2008","unstructured":"Lutskiy MI, Park JY, Remold SK, Remold-O'Donnell E. Evolution of highly polymorphic T cell populations in siblings with the Wiskott-Aldrich syndrome. PLoS One. 2008;3(10):e3444. https:\/\/doi.org\/10.1371\/journal.pone.0003444.","journal-title":"PLoS One"},{"issue":"1\u20133","key":"453_CR103","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12026-008-8091-4","volume":"44","author":"BR Davis","year":"2009","unstructured":"Davis BR, Candotti F. Revertant somatic mosaicism in the Wiskott-Aldrich syndrome. Immunol Res. 2009;44(1\u20133):127\u201331. https:\/\/doi.org\/10.1007\/s12026-008-8091-4.","journal-title":"Immunol Res"},{"issue":"1","key":"453_CR104","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.clim.2009.12.011","volume":"135","author":"BR Davis","year":"2010","unstructured":"Davis BR, Yan Q, Bui JH, Felix K, Moratto D, Muul LM, et al. Somatic mosaicism in the Wiskott-Aldrich syndrome: molecular and functional characterization of genotypic revertants. Clin Immunol. 2010;135(1):72\u201383. https:\/\/doi.org\/10.1016\/j.clim.2009.12.011.","journal-title":"Clin Immunol"},{"issue":"2","key":"453_CR105","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jaci.2009.11.034","volume":"125","author":"S Trifari","year":"2010","unstructured":"Trifari S, Scaramuzza S, Catucci M, Ponzoni M, Mollica L, Chiesa R, et al. Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: analysis of function and distribution in lymphoid organs. J Allergy Clin Immunol. 2010;125(2):439\u2013448 e8. https:\/\/doi.org\/10.1016\/j.jaci.2009.11.034.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"453_CR106","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.humimm.2015.04.001","volume":"76","author":"JW Xie","year":"2015","unstructured":"Xie JW, Zhang ZY, Wu JF, Liu DW, Liu W, Zhao Y, et al. In vivo reversion of an inherited mutation in a Chinese patient with Wiskott-Aldrich syndrome. Hum Immunol. 2015;76(6):406\u201313. https:\/\/doi.org\/10.1016\/j.humimm.2015.04.001.","journal-title":"Hum Immunol"},{"issue":"6","key":"453_CR107","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1182\/blood.V99.6.2268","volume":"99","author":"LD Notarangelo","year":"2002","unstructured":"Notarangelo LD, Mazza C, Giliani S, D'Aria C, Gandellini F, Ravelli C, et al. Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia. Blood. 2002;99(6):2268\u20139.","journal-title":"Blood"},{"issue":"1","key":"453_CR108","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12887-017-0897-6","volume":"17","author":"SS Medina","year":"2017","unstructured":"Medina SS, Siqueira LH, Colella MP, Yamaguti-Hayakawa GG, Duarte BKL, Dos Santos Vilela MM, et al. Intermittent low platelet counts hampering diagnosis of X-linked thrombocytopenia in children: report of two unrelated cases and a novel mutation in the gene coding for the Wiskott-Aldrich syndrome protein. BMC Pediatr. 2017;17(1):151. https:\/\/doi.org\/10.1186\/s12887-017-0897-6.","journal-title":"BMC Pediatr"},{"issue":"3","key":"453_CR109","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1751-553X.2009.01160.x","volume":"31","author":"C Briggs","year":"2009","unstructured":"Briggs C. Quality counts: new parameters in blood cell counting. Int J Lab Hematol. 2009;31(3):277\u201397.","journal-title":"Int J Lab Hematol"},{"key":"453_CR110","doi-asserted-by":"publisher","unstructured":"Zhou L, Li W, Zhang X, Liu D, Ding Y, Dai R, et al. Abnormal distribution of distinct lymphocyte subsets in children with Wiskott-Aldrich syndrome. Hum Immunol. 2017; https:\/\/doi.org\/10.1016\/j.humimm.2017.05.004.","DOI":"10.1016\/j.humimm.2017.05.004"},{"issue":"1","key":"453_CR111","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.clim.2014.09.003","volume":"155","author":"S Borte","year":"2014","unstructured":"Borte S, Fasth A, von Dobeln U, Winiarski J, Hammarstrom L. Newborn screening for severe T and B cell lymphopenia identifies a fraction of patients with Wiskott-Aldrich syndrome. Clin Immunol. 2014;155(1):74\u20138. https:\/\/doi.org\/10.1016\/j.clim.2014.09.003.","journal-title":"Clin Immunol"},{"issue":"7","key":"453_CR112","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/jama.2014.9132","volume":"312","author":"A Kwan","year":"2014","unstructured":"Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014;312(7):729\u201338. https:\/\/doi.org\/10.1001\/jama.2014.9132.","journal-title":"JAMA"},{"issue":"1","key":"453_CR113","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1084\/jem.20110896","volume":"209","author":"G Lanzi","year":"2012","unstructured":"Lanzi G, Moratto D, Vairo D, Masneri S, Delmonte O, Paganini T, et al. A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP. J Exp Med. 2012;209(1):29\u201334. https:\/\/doi.org\/10.1084\/jem.20110896.","journal-title":"J Exp Med"},{"key":"453_CR114","doi-asserted-by":"publisher","unstructured":"Gabelli M, Marzollo A, Notarangelo LD, Basso G, Putti MC. Eltrombopag use in a patient with Wiskott-Aldrich syndrome. Pediatr Blood Cancer. 2017; https:\/\/doi.org\/10.1002\/pbc.26692.","DOI":"10.1002\/pbc.26692"},{"issue":"1","key":"453_CR115","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10875-014-0105-5","volume":"35","author":"K Oshima","year":"2015","unstructured":"Oshima K, Imai K, Albert MH, Bittner TC, Strauss G, Filipovich AH, et al. Hematopoietic stem cell transplantation for X-linked thrombocytopenia with mutations in the WAS gene. J Clin Immunol. 2015;35(1):15\u201321. https:\/\/doi.org\/10.1007\/s10875-014-0105-5.","journal-title":"J Clin Immunol"},{"issue":"3","key":"453_CR116","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/(SICI)1096-8652(199911)62:3<183::AID-AJH8>3.0.CO;2-A","volume":"62","author":"G Young","year":"1999","unstructured":"Young G, Angiolillo AL. Long-term treatment of refractory thrombocytopenia in a patient with Wiskott-Aldrich syndrome with vincristine, immunoglobulin, and methylprednisolone. Am J Hematol. 1999;62(3):183\u20135.","journal-title":"Am J Hematol"},{"issue":"1","key":"453_CR117","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2141.2007.06616.x","volume":"138","author":"JJ Kim","year":"2007","unstructured":"Kim JJ, Thrasher AJ, Jones AM, Davies EG, Cale CM. Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency. Br J Haematol. 2007;138(1):94\u20136. https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06616.x.","journal-title":"Br J Haematol"},{"issue":"2","key":"453_CR118","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1001\/archdermatol.2010.434","volume":"147","author":"JT Huang","year":"2011","unstructured":"Huang JT, Rademaker A, Paller AS. Dilute bleach baths for Staphylococcus aureus colonization in atopic dermatitis to decrease disease severity. Arch Dermatol. 2011;147(2):246\u20137. https:\/\/doi.org\/10.1001\/archdermatol.2010.434.","journal-title":"Arch Dermatol"},{"key":"453_CR119","doi-asserted-by":"publisher","unstructured":"Jyonouchi S, Gwafila B, Gwalani LA, Ahmad M, Moertel C, Holbert C, et al. Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome. Clin Immunol. 2017; https:\/\/doi.org\/10.1016\/j.clim.2017.02.001.","DOI":"10.1016\/j.clim.2017.02.001."},{"issue":"583","key":"453_CR120","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/S0140-6736(68)92672-X","volume":"2","author":"FH Bach","year":"1968","unstructured":"Bach FH, Albertini RJ, Joo P, Anderson JL, Bortin MM. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet. 1968;2(583):1364\u20136.","journal-title":"Lancet"},{"issue":"17","key":"453_CR121","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJM197804272981701","volume":"298","author":"R Parkman","year":"1978","unstructured":"Parkman R, Rappeport J, Geha R, Belli J, Cassady R, Levey R, et al. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. N Engl J Med. 1978;298(17):921\u20137. https:\/\/doi.org\/10.1056\/NEJM197804272981701.","journal-title":"N Engl J Med"},{"issue":"1\u20133","key":"453_CR122","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12026-008-8063-8","volume":"44","author":"W Friedrich","year":"2009","unstructured":"Friedrich W, Schutz C, Schulz A, Benninghoff U, Honig M. Results and long-term outcome in 39 patients with Wiskott-Aldrich syndrome transplanted from HLA-matched and -mismatched donors. Immunol Res. 2009;44(1\u20133):18\u201324. https:\/\/doi.org\/10.1007\/s12026-008-8063-8.","journal-title":"Immunol Res"},{"issue":"11","key":"453_CR123","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/bmt.2012.31","volume":"47","author":"CR Shin","year":"2012","unstructured":"Shin CR, Kim MO, Li D, Bleesing JJ, Harris R, Mehta P, et al. Outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome. Bone Marrow Transplant. 2012;47(11):1428\u201335. https:\/\/doi.org\/10.1038\/bmt.2012.31.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"453_CR124","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1365-2141.2006.06297.x","volume":"135","author":"R Kobayashi","year":"2006","unstructured":"Kobayashi R, Ariga T, Nonoyama S, Kanegane H, Tsuchiya S, Morio T, et al. Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan. Br J Haematol. 2006;135(3):362\u20136. https:\/\/doi.org\/10.1111\/j.1365-2141.2006.06297.x.","journal-title":"Br J Haematol"},{"key":"453_CR125","doi-asserted-by":"publisher","unstructured":"Shekhovtsova Z, Bonfim C, Ruggeri A, Nichele S, Page K, AlSeraihy A, et al. A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome. Haematologica. 2017; https:\/\/doi.org\/10.3324\/haematol.2016.158808.","DOI":"10.3324\/haematol.2016.158808"},{"issue":"5","key":"453_CR126","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.jaci.2014.04.041","volume":"134","author":"G Kharya","year":"2014","unstructured":"Kharya G, Nademi Z, Leahy TR, Dunn J, Barge D, Schulz A, et al. Haploidentical T-cell alpha beta receptor and CD19-depleted stem cell transplant for Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2014;134(5):1199\u2013201. https:\/\/doi.org\/10.1016\/j.jaci.2014.04.041.","journal-title":"J Allergy Clin Immunol"},{"issue":"20","key":"453_CR127","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1056\/NEJMoa1003548","volume":"363","author":"K Boztug","year":"2010","unstructured":"Boztug K, Schmidt M, Schwarzer A, Banerjee PP, Diez IA, Dewey RA, et al. Stem-cell gene therapy for the Wiskott-Aldrich syndrome. N Engl J Med. 2010;363(20):1918\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1003548.","journal-title":"N Engl J Med"},{"issue":"227","key":"453_CR128","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007280","volume":"6","author":"CJ Braun","year":"2014","unstructured":"Braun CJ, Boztug K, Paruzynski A, Witzel M, Schwarzer A, Rothe M, et al. Gene therapy for Wiskott-Aldrich syndrome\u2014long-term efficacy and genotoxicity. Sci Transl Med. 2014;6(227):227ra33. https:\/\/doi.org\/10.1126\/scitranslmed.3007280.","journal-title":"Sci Transl Med"},{"issue":"5","key":"453_CR129","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.ymthe.2004.08.008","volume":"10","author":"L Dupre","year":"2004","unstructured":"Dupre L, Trifari S, Follenzi A, Marangoni F, Lain de Lera T, Bernad A, et al. Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction. Mol Ther. 2004;10(5):903\u201315.","journal-title":"Mol Ther"},{"key":"453_CR130","doi-asserted-by":"publisher","unstructured":"Aiuti A, Biasco L, Scaramuzza S, Ferrua F, Cicalese MP, Baricordi C, et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science. 2013; https:\/\/doi.org\/10.1126\/science.1233151.","DOI":"10.1126\/science.1233151"},{"issue":"23","key":"453_CR131","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V126.23.259.259","volume":"126","author":"F Ferrua","year":"2015","unstructured":"Ferrua F, Cicalese MP, Galimberti S, Scaramuzza S, Giannelli S, Pajno R, et al. Safety and clinical benefit of lentiviral hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome. Blood. 2015;126(23):3.","journal-title":"Blood"},{"issue":"3","key":"453_CR132","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jaci.2015.01.035","volume":"136","author":"MC Castiello","year":"2015","unstructured":"Castiello MC, Scaramuzza S, Pala F, Ferrua F, Uva P, Brigida I, et al. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2015;136(3):692\u2013702 e2. https:\/\/doi.org\/10.1016\/j.jaci.2015.01.035.","journal-title":"J Allergy Clin Immunol"},{"issue":"15","key":"453_CR133","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1001\/jama.2015.3253","volume":"313","author":"S Hacein-Bey Abina","year":"2015","unstructured":"Hacein-Bey Abina S, Gaspar HB, Blondeau J, Caccavelli L, Charrier S, Buckland K, et al. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome. JAMA. 2015;313(15):1550\u201363. https:\/\/doi.org\/10.1001\/jama.2015.3253.","journal-title":"JAMA"},{"issue":"23","key":"453_CR134","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood.V126.23.260.260","volume":"126","author":"JI Chu","year":"2015","unstructured":"Chu JI, Henderson LA, Armant M, Male F, Dansereau CH, MacKinnon B, et al. Gene therapy using a self-inactivating lentiviral vector improves clinical and laboratory manifestations of Wiskott-Aldrich syndrome. Blood. 2015;126(23):260.","journal-title":"Blood"},{"issue":"2","key":"453_CR135","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/humc.2012.244","volume":"24","author":"RM Koldej","year":"2013","unstructured":"Koldej RM, Carney G, Wielgosz MM, Zhou S, Zhan J, Sorrentino BP, et al. Comparison of insulators and promoters for expression of the Wiskott-Aldrich syndrome protein using lentiviral vectors. Hum Gene Ther Clin Dev. 2013;24(2):77\u201385. https:\/\/doi.org\/10.1089\/humc.2012.244.","journal-title":"Hum Gene Ther Clin Dev"},{"key":"453_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2014.63","volume":"2","author":"MM Wielgosz","year":"2015","unstructured":"Wielgosz MM, Kim YS, Carney GG, Zhan J, Reddivari M, Coop T, et al. Generation of a lentiviral vector producer cell clone for human Wiskott-Aldrich syndrome gene therapy. Mol Ther Methods Clin Dev. 2015;2:14063. https:\/\/doi.org\/10.1038\/mtm.2014.63.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"6","key":"453_CR137","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/mt.2011.282","volume":"20","author":"T Uchiyama","year":"2012","unstructured":"Uchiyama T, Adriani M, Jagadeesh GJ, Paine A, Candotti F. Foamy virus vector-mediated gene correction of a mouse model of Wiskott-Aldrich syndrome. Mol Ther. 2012;20(6):1270\u20139. https:\/\/doi.org\/10.1038\/mt.2011.282.","journal-title":"Mol Ther"},{"issue":"2","key":"453_CR138","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jaci.2016.01.051","volume":"138","author":"LM Griffith","year":"2016","unstructured":"Griffith LM, Cowan MJ, Notarangelo LD, Kohn DB, Puck JM, Shearer WT, et al. Primary Immune Deficiency Treatment Consortium (PIDTC) update. J Allergy Clin Immunol. 2016;138(2):375\u201385. https:\/\/doi.org\/10.1016\/j.jaci.2016.01.051.","journal-title":"J Allergy Clin Immunol"},{"issue":"22","key":"453_CR139","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1182\/blood.V128.22.366.366","volume":"128","author":"JS Glasmacher","year":"2016","unstructured":"Glasmacher JS, Bittner TC, Ochs HD, Aiuti A, Arkwright PD, Balashov D, et al. Wiskott-Aldrich syndrome: a retrospective study on 575 patients analyzing the impact of splenectomy, stem cell transplantation, or no definitive treatment on frequency of disease-related complications and physician-perceived quality of life. Blood. 2016;128(22):366.","journal-title":"Blood"},{"issue":"2","key":"453_CR140","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.stemcr.2016.06.003","volume":"7","author":"TJ Laskowski","year":"2016","unstructured":"Laskowski TJ, Van Caeneghem Y, Pourebrahim R, Ma C, Ni Z, Garate Z, et al. Gene correction of iPSCs from a Wiskott-Aldrich syndrome patient normalizes the lymphoid developmental and functional defects. Stem Cell Rep. 2016;7(2):139\u201348. https:\/\/doi.org\/10.1016\/j.stemcr.2016.06.003.","journal-title":"Stem Cell Rep"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-017-0453-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-017-0453-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-017-0453-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T18:54:17Z","timestamp":1693162457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-017-0453-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,30]]},"references-count":140,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["453"],"URL":"https:\/\/doi.org\/10.1007\/s10875-017-0453-z","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,30]]},"assertion":[{"value":"17 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The author declares that he has no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}